ubenimex
antileukemic
bortezomib
lasinavir
palinavir
telinavir
sepimostat
candoxatrilat
ixazomib
thioguanine
vosaroxin
idelalisib
aloxistatin
talacotuzumab
venetoclax
omacetaxine
murinoglobulin
spumigin
epoxomicin
bestatin
ponatinib
ecabet
denagliptin
asciminib
chloraminophene
leukoprotease
danoprevir
clofarabine
protealide
tyrosine kinase inhibitor
gemtuzumab ozogamicin
cystatin
pegaspargase
chelidostatin
folliculin
promyeloleukemia
ticolubant
ribociclib
immunokinase
mercaptopurine
lenzilumab
antiprotease
piposulfan
forodesine
antileukemia
gilteritinib
kalicludin
mubritinib
sotrastaurin
ivosidenib
ofatumumab
homoharringtonine
alemtuzumab
olutasidenib
trilaciclib
pelitinib
proprotease
roscovitine
tucatinib
boceprevir
azaguanine
chloromercuribenzoic acid
tagitinine
stefin
antiprostaglandin
proteinase
glecaprevir
nonleukemic
leukemogenicity
phenylmethylsulfonylfluoride
multicorn
phenylmethanesulfonylfluoride
alveolin
paludrine
506U78
proteotoxin
cytarabine
telaprevir
caspase
HER-2
ubistatin
ipatasertib
livin
belumosudil
succinylproteome
proteoclastic
leukemic
parafibromin
chymostatin
proteolytical
anamorsin
thymoglobulin
nonleukemogenic
aprotinin
preprosomatostatin
fludarabine
immunoproteome
paullone
tigatuzumab